Feasibility of safe ultra-high (EQD2>100 Gy) dose escalation on dominant intra-prostatic lesions (DILs) by Helical Tomotheraphy

Author： Maggio Angelo   Fiorino Claudio   Mangili Paola   Cozzarini Cesare   de Cobelli Francesco   Cattaneo Giovanni Mauro   Rancati Tiziana   Maschio Alessandro Del   Muzio Nadia Di   Calandrino Riccardo  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.50, Iss.1, 2011-01, pp. : 25-34

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ultra-high Dose-rate Effects in Radiosensitive Bacteria

By Phillips Theodore L.   Worsnop B. Ralph  

International Journal of Radiation Biology, Vol. 14, Iss. 6, 1969-01 ,pp. : 573-575

Informa Healthcare

Access to resources Recommend Favorite

Feasibility and sensitivity study of helical tomotherapy for dose painting plans

By Deveau Michael A.   Bowen Stephen R.   Westerly David C.   Jeraj Robert  

Acta Oncologica, Vol. 49, Iss. 7, 2010-10 ,pp. : 991-996

Informa Healthcare

Access to resources Recommend Favorite

Oxygen Depletion in Cells Irradiated at Ultra-high Dose-rates and at Conventional Dose-rates

By Weiss H.   Epp E.R.   Heslin J.M.   Ling C.C.   Santomasso A.  

International Journal of Radiation Biology, Vol. 26, Iss. 1, 1974-07 ,pp. : 17-29

Informa Healthcare

Access to resources Recommend Favorite

Intra-Arterial Continuous Infusion for Treatment of Pancreatic and Biliary Tract Cancer: A Dose-Escalation Study of Fluorouracil Combined with Gemcitabine

By  

International Journal of Gastrointestinal Cancer, Vol. 27, Iss. 3, 2000-06 ,pp. : 225-234

Humana Press, Inc

Access to resources Recommend Favorite

Pharmacokinetic linearity of i.v. vinorelbine from an intra-patient dose escalation study design

By Khayat David   Rixe Olivier   Brunet René   Goupil Alain   Bugat Roland   Harousseau Jean-Luc   Ifrah Norbert   Puozzo Christian  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 3, 2004-09 ,pp. : 193-205

Springer Publishing Company

Access to resources Recommend Favorite